Salbutamol Completed Phase 4 Trials for Reactive Airway Exacerbation / Asthma Bronchial / Asthma Acute Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00393367Budesonide Inhalation Suspension for Acute Asthma in Children
NCT00831376Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
NCT03380429A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects
NCT00363480Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
NCT00530062Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
NCT00315744Viapaed Study In Children And Adolescents With Asthma
NCT00124176Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
NCT00272753Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
NCT00567476Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
NCT00585039Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
NCT00940927Dose-response of Albuterol in Asthmatics
NCT01091337Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
NCT02182713Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm